Bruker Application Note
The amaZon series is the next step in Bruker Daltonics' family of ion trap mass spectrometers. Incorporating a number of new innovations to Bruker's highly successful ion trap technology platforms, the amaZon series is a true leap forward in performance and reliability.
Figure 1: Direct injection of 50â750 fg reserpine. Even at 50 fg in MSâMS mode, the amaZon is able to achieve at 50:1 S/N. Note also the excellent reproducibility in these five replicate injections.
The performance of the amaZon X Ion Trap System has been tested in terms of sensitivity, speed and dynamic range for small molecule analysis.
Figure 2: Dynamic range of amaZon. In this example 1â10000 ppb of melamine on column was measured by the amaZon. This correlates to at least 4 orders of magnitude dynamic range with outstanding linearity.
It has been shown that the amaZon is easily capable of detecting low femtagrams of a small molecule on column. The amaZon also displays a dynamic range of at least four orders of magnitude when quantifying small molecules in the ppb to ppm range. The instrument also possesses the capability to do "Zero Delay" polarity switching, even at UPLC separation speeds.
Figure 3: Speed of amaZon. In this example, a compound in plasma separated by UPLC with a 1 sec peak width is measured at 20 Hz in positive and negative ion mode with "zero delay" alternating ionization switching.
All of these attributes demonstrate the high performance capabilities of the amaZon and demonstrate its suitability for deployment in a number of small molecule analysis areas.
Bruker Daltonics Inc.
Billerica, Massachusetts, USA
tel. +1 978 663 3660 fax +1 978 667 5993
E-mail: ms-sales@bdal.com
Website: www.bdal.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.